Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Simian immunodeficiency virus | 89 | 2023 | 805 | 17.110 |
Why?
|
AIDS Vaccines | 99 | 2024 | 895 | 16.670 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 70 | 2023 | 538 | 15.810 |
Why?
|
Antibodies, Neutralizing | 115 | 2024 | 1933 | 14.460 |
Why?
|
Adenoviridae | 65 | 2021 | 1084 | 12.300 |
Why?
|
Macaca mulatta | 147 | 2024 | 2316 | 12.270 |
Why?
|
Viral Vaccines | 47 | 2023 | 596 | 12.210 |
Why?
|
HIV-1 | 127 | 2024 | 6849 | 10.910 |
Why?
|
Antibodies, Viral | 106 | 2024 | 3143 | 10.640 |
Why?
|
HIV Antibodies | 57 | 2024 | 1300 | 7.760 |
Why?
|
Genetic Vectors | 74 | 2023 | 3380 | 7.220 |
Why?
|
SAIDS Vaccines | 31 | 2020 | 144 | 7.020 |
Why?
|
Adenoviruses, Human | 25 | 2024 | 255 | 6.720 |
Why?
|
Vaccines, DNA | 42 | 2020 | 286 | 5.580 |
Why?
|
Immunity, Cellular | 39 | 2022 | 1557 | 5.370 |
Why?
|
Immunization, Secondary | 20 | 2024 | 368 | 5.340 |
Why?
|
Vaccines, Synthetic | 41 | 2023 | 617 | 4.980 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 26 | 2024 | 368 | 4.570 |
Why?
|
HIV Infections | 103 | 2024 | 17165 | 4.490 |
Why?
|
Immunity, Humoral | 27 | 2022 | 604 | 4.100 |
Why?
|
Immunity, Mucosal | 15 | 2024 | 482 | 3.900 |
Why?
|
CD4-Positive T-Lymphocytes | 44 | 2023 | 4353 | 3.470 |
Why?
|
CD8-Positive T-Lymphocytes | 50 | 2024 | 4550 | 3.410 |
Why?
|
Vaccination | 64 | 2024 | 3361 | 3.060 |
Why?
|
Capsid Proteins | 15 | 2024 | 467 | 2.990 |
Why?
|
Viral Load | 44 | 2024 | 3322 | 2.690 |
Why?
|
Animals | 274 | 2024 | 167963 | 2.630 |
Why?
|
Gene Products, env | 13 | 2020 | 250 | 2.520 |
Why?
|
Anti-Retroviral Agents | 18 | 2023 | 1779 | 2.510 |
Why?
|
Antigens, Viral | 21 | 2023 | 980 | 2.340 |
Why?
|
Lymphocytic choriomeningitis virus | 7 | 2021 | 177 | 2.300 |
Why?
|
Virus Replication | 27 | 2023 | 2432 | 2.250 |
Why?
|
Cross Reactions | 13 | 2022 | 818 | 2.180 |
Why?
|
Immunization, Passive | 12 | 2022 | 616 | 2.170 |
Why?
|
Adenovirus Infections, Human | 7 | 2024 | 73 | 2.140 |
Why?
|
Immunologic Memory | 19 | 2021 | 1354 | 2.020 |
Why?
|
Vaccines | 14 | 2023 | 832 | 1.970 |
Why?
|
Gene Products, gag | 24 | 2020 | 312 | 1.970 |
Why?
|
T-Lymphocytes | 40 | 2024 | 10181 | 1.960 |
Why?
|
Vaccinia virus | 14 | 2024 | 331 | 1.890 |
Why?
|
Adenoviridae Infections | 8 | 2024 | 93 | 1.870 |
Why?
|
Toll-Like Receptor 7 | 6 | 2022 | 177 | 1.770 |
Why?
|
Antibody Formation | 14 | 2024 | 1400 | 1.770 |
Why?
|
Drug Carriers | 11 | 2018 | 709 | 1.760 |
Why?
|
Epitopes | 24 | 2023 | 2503 | 1.750 |
Why?
|
Epitopes, T-Lymphocyte | 19 | 2021 | 824 | 1.670 |
Why?
|
Adjuvants, Immunologic | 16 | 2024 | 1039 | 1.660 |
Why?
|
Immunoglobulin G | 27 | 2024 | 4541 | 1.610 |
Why?
|
T-Lymphocytes, Cytotoxic | 27 | 2021 | 1765 | 1.470 |
Why?
|
Neutralization Tests | 22 | 2022 | 728 | 1.470 |
Why?
|
Pandemics | 18 | 2024 | 8624 | 1.400 |
Why?
|
Macaca | 10 | 2023 | 409 | 1.380 |
Why?
|
Immunity, Innate | 17 | 2023 | 3047 | 1.350 |
Why?
|
HIV Envelope Protein gp120 | 11 | 2021 | 915 | 1.340 |
Why?
|
Viremia | 11 | 2022 | 707 | 1.280 |
Why?
|
Smallpox Vaccine | 3 | 2024 | 77 | 1.260 |
Why?
|
Coronavirus Infections | 9 | 2020 | 3085 | 1.240 |
Why?
|
Pneumonia, Viral | 9 | 2020 | 3205 | 1.220 |
Why?
|
Disease Models, Animal | 28 | 2022 | 18137 | 1.220 |
Why?
|
Mice, Inbred BALB C | 29 | 2022 | 6216 | 1.210 |
Why?
|
Injections, Intramuscular | 16 | 2023 | 553 | 1.200 |
Why?
|
HIV Seropositivity | 4 | 2023 | 955 | 1.200 |
Why?
|
Antibodies, Monoclonal | 20 | 2023 | 9185 | 1.180 |
Why?
|
Cytokines | 20 | 2024 | 7343 | 1.160 |
Why?
|
Immunization | 18 | 2024 | 1227 | 1.110 |
Why?
|
HIV | 11 | 2022 | 1579 | 1.100 |
Why?
|
Immunoglobulin A | 7 | 2024 | 979 | 1.090 |
Why?
|
Lymphocyte Depletion | 4 | 2018 | 602 | 1.070 |
Why?
|
Humans | 259 | 2024 | 760621 | 1.070 |
Why?
|
Adenoviruses, Simian | 3 | 2024 | 15 | 1.060 |
Why?
|
Killer Cells, Natural | 8 | 2023 | 2203 | 1.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 2018 | 2197 | 1.030 |
Why?
|
Immunity, Maternally-Acquired | 4 | 2020 | 111 | 1.020 |
Why?
|
Mice | 87 | 2024 | 81208 | 1.010 |
Why?
|
DNA, Viral | 13 | 2021 | 2194 | 1.000 |
Why?
|
Viral Envelope Proteins | 11 | 2023 | 638 | 0.990 |
Why?
|
RNA, Viral | 14 | 2021 | 2838 | 0.990 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 7 | 2024 | 206 | 0.980 |
Why?
|
Vaccines, Inactivated | 4 | 2020 | 180 | 0.970 |
Why?
|
Adoptive Transfer | 10 | 2020 | 822 | 0.950 |
Why?
|
Vaccines, Attenuated | 4 | 2020 | 314 | 0.910 |
Why?
|
Thrombosis | 3 | 2023 | 3052 | 0.890 |
Why?
|
Monkeypox virus | 1 | 2023 | 42 | 0.890 |
Why?
|
Lymphocytic Choriomeningitis | 4 | 2021 | 139 | 0.890 |
Why?
|
Mice, Inbred C57BL | 38 | 2021 | 22023 | 0.880 |
Why?
|
Plasmids | 19 | 2011 | 2275 | 0.850 |
Why?
|
Tuberculosis Vaccines | 3 | 2020 | 48 | 0.850 |
Why?
|
Dengue | 4 | 2023 | 254 | 0.840 |
Why?
|
Female | 122 | 2024 | 391270 | 0.830 |
Why?
|
Mucous Membrane | 5 | 2019 | 657 | 0.790 |
Why?
|
Immune Evasion | 3 | 2023 | 362 | 0.780 |
Why?
|
Listeria monocytogenes | 2 | 2014 | 248 | 0.770 |
Why?
|
Dengue Vaccines | 1 | 2021 | 16 | 0.770 |
Why?
|
Nucleosides | 1 | 2021 | 131 | 0.750 |
Why?
|
Capsid | 2 | 2021 | 434 | 0.750 |
Why?
|
Antiviral Agents | 4 | 2022 | 3061 | 0.720 |
Why?
|
Cancer Vaccines | 5 | 2021 | 1046 | 0.710 |
Why?
|
alpha-Defensins | 1 | 2019 | 30 | 0.700 |
Why?
|
Interleukin-2 | 12 | 2014 | 1889 | 0.700 |
Why?
|
Guinea Pigs | 8 | 2019 | 1316 | 0.690 |
Why?
|
Cricetinae | 6 | 2022 | 2427 | 0.670 |
Why?
|
Integrin alpha4 | 1 | 2019 | 87 | 0.670 |
Why?
|
Integrin beta Chains | 1 | 2019 | 115 | 0.660 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2019 | 112 | 0.650 |
Why?
|
Double-Blind Method | 20 | 2024 | 12427 | 0.640 |
Why?
|
Male | 90 | 2024 | 359744 | 0.640 |
Why?
|
Gene Expression Regulation, Viral | 3 | 2019 | 438 | 0.640 |
Why?
|
Immunodominant Epitopes | 6 | 2006 | 241 | 0.630 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2018 | 92 | 0.620 |
Why?
|
Transduction, Genetic | 3 | 2018 | 897 | 0.620 |
Why?
|
Adaptive Immunity | 7 | 2023 | 726 | 0.620 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.610 |
Why?
|
Fetal Blood | 2 | 2021 | 1343 | 0.590 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 15 | 2017 | 3804 | 0.580 |
Why?
|
Intestinal Mucosa | 6 | 2014 | 3022 | 0.570 |
Why?
|
Bronchoalveolar Lavage Fluid | 5 | 2021 | 748 | 0.570 |
Why?
|
Virulence Factors | 1 | 2020 | 511 | 0.560 |
Why?
|
Immunoglobulin Fc Fragments | 6 | 2018 | 280 | 0.560 |
Why?
|
Lymphocyte Activation | 11 | 2021 | 5496 | 0.560 |
Why?
|
Primates | 8 | 2022 | 523 | 0.560 |
Why?
|
Foreskin | 2 | 2014 | 31 | 0.550 |
Why?
|
Milk, Human | 1 | 2021 | 483 | 0.550 |
Why?
|
Placenta | 2 | 2023 | 1702 | 0.540 |
Why?
|
Lymphoid Tissue | 3 | 2022 | 445 | 0.520 |
Why?
|
HLA-A2 Antigen | 8 | 2011 | 211 | 0.510 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1174 | 0.510 |
Why?
|
Nanoparticles | 3 | 2023 | 1943 | 0.510 |
Why?
|
Host-Pathogen Interactions | 4 | 2021 | 1447 | 0.500 |
Why?
|
Gene Products, pol | 5 | 2020 | 43 | 0.500 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 562 | 0.490 |
Why?
|
Canarypox virus | 2 | 2013 | 10 | 0.490 |
Why?
|
Arenaviridae Infections | 1 | 2015 | 53 | 0.490 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 2 | 2016 | 148 | 0.480 |
Why?
|
Dendritic Cells | 6 | 2019 | 2725 | 0.480 |
Why?
|
Clinical Trials as Topic | 13 | 2020 | 8056 | 0.480 |
Why?
|
pol Gene Products, Human Immunodeficiency Virus | 2 | 2012 | 39 | 0.470 |
Why?
|
B-Lymphocytes | 8 | 2024 | 4742 | 0.470 |
Why?
|
Inflammasomes | 2 | 2016 | 530 | 0.460 |
Why?
|
Cloning, Molecular | 3 | 2018 | 4169 | 0.460 |
Why?
|
Mesocricetus | 4 | 2022 | 252 | 0.460 |
Why?
|
Leukocytes, Mononuclear | 8 | 2024 | 1827 | 0.460 |
Why?
|
Peptide Fragments | 8 | 2021 | 5125 | 0.450 |
Why?
|
Vaccines, Subunit | 4 | 2024 | 161 | 0.440 |
Why?
|
Adult | 48 | 2024 | 219994 | 0.440 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1229 | 0.440 |
Why?
|
Lymph Nodes | 4 | 2024 | 3486 | 0.430 |
Why?
|
Serum | 1 | 2014 | 211 | 0.430 |
Why?
|
Endosomes | 2 | 2024 | 519 | 0.430 |
Why?
|
Listeriosis | 1 | 2014 | 148 | 0.430 |
Why?
|
Serotyping | 6 | 2012 | 324 | 0.430 |
Why?
|
Young Adult | 28 | 2024 | 58741 | 0.420 |
Why?
|
Vascular Diseases | 2 | 2021 | 1182 | 0.420 |
Why?
|
Immunoglobulins | 3 | 2016 | 859 | 0.420 |
Why?
|
Viral Hepatitis Vaccines | 1 | 2012 | 75 | 0.420 |
Why?
|
Immunization Schedule | 4 | 2020 | 224 | 0.410 |
Why?
|
Immune System Diseases | 1 | 2015 | 258 | 0.410 |
Why?
|
Amino Acid Sequence | 21 | 2021 | 13451 | 0.410 |
Why?
|
HIV Antigens | 6 | 2016 | 325 | 0.400 |
Why?
|
RNA, Messenger | 8 | 2024 | 12766 | 0.400 |
Why?
|
Bacterial Vaccines | 1 | 2014 | 401 | 0.390 |
Why?
|
Cell Movement | 6 | 2021 | 5206 | 0.380 |
Why?
|
Molecular Sequence Data | 25 | 2014 | 17624 | 0.380 |
Why?
|
Antigen-Presenting Cells | 3 | 2008 | 967 | 0.380 |
Why?
|
Immune System | 2 | 2014 | 798 | 0.370 |
Why?
|
Vitamin A Deficiency | 1 | 2011 | 88 | 0.370 |
Why?
|
Fetus | 1 | 2018 | 1859 | 0.360 |
Why?
|
Chemokines | 4 | 2012 | 962 | 0.360 |
Why?
|
Peptides | 4 | 2021 | 4354 | 0.360 |
Why?
|
Germinal Center | 3 | 2017 | 379 | 0.350 |
Why?
|
Genome, Viral | 4 | 2019 | 658 | 0.350 |
Why?
|
Macaca fascicularis | 3 | 2021 | 900 | 0.340 |
Why?
|
Administration, Intranasal | 4 | 2023 | 471 | 0.340 |
Why?
|
Placebos | 5 | 2021 | 1668 | 0.340 |
Why?
|
Antibodies | 2 | 2016 | 2421 | 0.340 |
Why?
|
Caliciviridae | 2 | 2023 | 5 | 0.330 |
Why?
|
RNA Viruses | 2 | 2023 | 110 | 0.330 |
Why?
|
Rectum | 4 | 2016 | 895 | 0.320 |
Why?
|
Inflammation | 6 | 2022 | 10756 | 0.320 |
Why?
|
Virus Latency | 3 | 2022 | 362 | 0.310 |
Why?
|
Drug Design | 3 | 2018 | 1061 | 0.310 |
Why?
|
Immunogenetics | 1 | 2008 | 66 | 0.310 |
Why?
|
Gastric Mucosa | 1 | 2011 | 599 | 0.310 |
Why?
|
Smallpox | 1 | 2008 | 43 | 0.300 |
Why?
|
Evolution, Molecular | 2 | 2015 | 1885 | 0.300 |
Why?
|
Dengue Virus | 4 | 2023 | 200 | 0.300 |
Why?
|
Viral Proteins | 6 | 2021 | 1802 | 0.300 |
Why?
|
Histocompatibility Antigens Class I | 5 | 2024 | 1355 | 0.300 |
Why?
|
Influenza in Birds | 1 | 2008 | 76 | 0.300 |
Why?
|
CD4 Lymphocyte Count | 9 | 2022 | 2569 | 0.290 |
Why?
|
Pregnancy | 8 | 2024 | 29749 | 0.290 |
Why?
|
Seroepidemiologic Studies | 4 | 2014 | 394 | 0.290 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.280 |
Why?
|
Nucleocapsid | 2 | 2024 | 63 | 0.280 |
Why?
|
Lentivirus | 2 | 2018 | 506 | 0.280 |
Why?
|
Virulence | 3 | 2022 | 1298 | 0.280 |
Why?
|
Phylogeny | 7 | 2024 | 2775 | 0.280 |
Why?
|
Nasal Mucosa | 2 | 2020 | 412 | 0.280 |
Why?
|
Middle Aged | 34 | 2024 | 220352 | 0.280 |
Why?
|
Gene Expression | 4 | 2021 | 7588 | 0.280 |
Why?
|
Vagina | 5 | 2019 | 837 | 0.280 |
Why?
|
Interferon-gamma | 10 | 2018 | 3157 | 0.280 |
Why?
|
Toll-Like Receptor 4 | 1 | 2010 | 580 | 0.280 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2023 | 3075 | 0.270 |
Why?
|
Lung | 9 | 2023 | 9994 | 0.270 |
Why?
|
Antigen Presentation | 5 | 2021 | 1254 | 0.270 |
Why?
|
Immunoassay | 2 | 2021 | 746 | 0.260 |
Why?
|
Administration, Oral | 3 | 2021 | 4035 | 0.260 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2020 | 1348 | 0.260 |
Why?
|
Reassortant Viruses | 1 | 2005 | 36 | 0.260 |
Why?
|
Receptors, IgG | 2 | 2020 | 559 | 0.250 |
Why?
|
Inhibitory Concentration 50 | 4 | 2020 | 465 | 0.250 |
Why?
|
Hepacivirus | 1 | 2012 | 1334 | 0.250 |
Why?
|
Terminal Repeat Sequences | 1 | 2005 | 70 | 0.250 |
Why?
|
Mice, Knockout | 7 | 2021 | 14372 | 0.250 |
Why?
|
Genetic Variation | 7 | 2020 | 6551 | 0.250 |
Why?
|
Viral Nonstructural Proteins | 2 | 2019 | 223 | 0.250 |
Why?
|
Models, Animal | 4 | 2020 | 2117 | 0.240 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2005 | 142 | 0.240 |
Why?
|
Drug Delivery Systems | 2 | 2021 | 2221 | 0.240 |
Why?
|
Immunologic Factors | 2 | 2014 | 1588 | 0.240 |
Why?
|
Antibody Specificity | 4 | 2016 | 1060 | 0.240 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 981 | 0.240 |
Why?
|
Proviruses | 4 | 2023 | 313 | 0.240 |
Why?
|
Cytomegalovirus | 3 | 2018 | 755 | 0.240 |
Why?
|
Zeolites | 1 | 2024 | 10 | 0.240 |
Why?
|
Lactation | 2 | 2021 | 397 | 0.240 |
Why?
|
Genes, Regulator | 1 | 2005 | 374 | 0.230 |
Why?
|
T-Lymphocyte Subsets | 5 | 2018 | 1810 | 0.230 |
Why?
|
Bronchoalveolar Lavage | 2 | 2021 | 129 | 0.220 |
Why?
|
Lymphocytes | 1 | 2011 | 2611 | 0.220 |
Why?
|
Dose-Response Relationship, Immunologic | 6 | 2021 | 365 | 0.220 |
Why?
|
Fourier Analysis | 1 | 2024 | 439 | 0.220 |
Why?
|
Adolescent | 19 | 2024 | 87810 | 0.220 |
Why?
|
Caliciviridae Infections | 1 | 2023 | 29 | 0.220 |
Why?
|
Receptors, Fc | 4 | 2022 | 534 | 0.220 |
Why?
|
Colony-Stimulating Factors | 1 | 2003 | 218 | 0.220 |
Why?
|
Norovirus | 1 | 2023 | 36 | 0.210 |
Why?
|
Africa South of the Sahara | 3 | 2014 | 742 | 0.210 |
Why?
|
Vaccines, Combined | 1 | 2023 | 70 | 0.210 |
Why?
|
Kinetics | 6 | 2021 | 6377 | 0.210 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 4 | 2017 | 303 | 0.210 |
Why?
|
Base Sequence | 13 | 2017 | 12446 | 0.210 |
Why?
|
Viruses | 2 | 2017 | 376 | 0.210 |
Why?
|
Hepatitis C | 1 | 2012 | 1579 | 0.200 |
Why?
|
Protein Multimerization | 4 | 2018 | 983 | 0.200 |
Why?
|
Protein Binding | 11 | 2021 | 9335 | 0.200 |
Why?
|
Virus Activation | 2 | 2022 | 319 | 0.200 |
Why?
|
Brazil | 2 | 2016 | 1218 | 0.200 |
Why?
|
Monkey Diseases | 2 | 2017 | 71 | 0.200 |
Why?
|
Aluminum Hydroxide | 1 | 2022 | 54 | 0.200 |
Why?
|
Alleles | 8 | 2024 | 6898 | 0.200 |
Why?
|
Cystitis | 1 | 2002 | 96 | 0.200 |
Why?
|
Vero Cells | 2 | 2020 | 482 | 0.200 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2020 | 361 | 0.200 |
Why?
|
Time Factors | 10 | 2020 | 40165 | 0.190 |
Why?
|
Caspase 1 | 1 | 2022 | 226 | 0.190 |
Why?
|
Antigens, Neoplasm | 3 | 2021 | 1998 | 0.190 |
Why?
|
Immunoglobulin M | 3 | 2020 | 1529 | 0.190 |
Why?
|
BK Virus | 1 | 2002 | 123 | 0.190 |
Why?
|
Viral Interference | 1 | 2021 | 12 | 0.190 |
Why?
|
Recombinant Fusion Proteins | 9 | 2011 | 3735 | 0.190 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 176 | 0.190 |
Why?
|
Genetic Engineering | 2 | 2006 | 933 | 0.190 |
Why?
|
Proteome | 2 | 2021 | 1855 | 0.180 |
Why?
|
Herpesviridae | 1 | 2001 | 106 | 0.180 |
Why?
|
Communicable Diseases | 2 | 2023 | 878 | 0.180 |
Why?
|
Nose | 2 | 2021 | 519 | 0.180 |
Why?
|
Sequence Alignment | 5 | 2017 | 2176 | 0.180 |
Why?
|
Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
Toll-Like Receptors | 3 | 2024 | 590 | 0.180 |
Why?
|
Receptors, CXCR3 | 1 | 2021 | 238 | 0.180 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 76 | 0.180 |
Why?
|
Proteomics | 2 | 2024 | 3817 | 0.180 |
Why?
|
Protein Engineering | 2 | 2021 | 541 | 0.180 |
Why?
|
Epitope Mapping | 3 | 2020 | 297 | 0.180 |
Why?
|
Ferritins | 1 | 2023 | 597 | 0.170 |
Why?
|
Interleukin-6 | 2 | 2021 | 3215 | 0.170 |
Why?
|
Ferrets | 1 | 2020 | 176 | 0.170 |
Why?
|
Genes, env | 2 | 2010 | 95 | 0.170 |
Why?
|
High-Throughput Screening Assays | 2 | 2017 | 944 | 0.170 |
Why?
|
Enzyme-Linked Immunospot Assay | 3 | 2016 | 123 | 0.170 |
Why?
|
Drug Discovery | 2 | 2020 | 1057 | 0.170 |
Why?
|
Sequence Analysis | 1 | 2020 | 240 | 0.170 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2004 | 886 | 0.170 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2017 | 1351 | 0.170 |
Why?
|
Primate Diseases | 2 | 2013 | 15 | 0.170 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2019 | 153 | 0.160 |
Why?
|
DNA Primers | 7 | 2007 | 2819 | 0.160 |
Why?
|
Codon, Terminator | 1 | 2019 | 125 | 0.160 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1454 | 0.160 |
Why?
|
Single-Chain Antibodies | 1 | 2019 | 111 | 0.160 |
Why?
|
Virion | 1 | 2021 | 421 | 0.160 |
Why?
|
Stromal Cells | 1 | 2024 | 1326 | 0.160 |
Why?
|
Macrophages | 3 | 2024 | 5745 | 0.160 |
Why?
|
Factor X | 2 | 2009 | 64 | 0.160 |
Why?
|
HIV-2 | 1 | 2019 | 156 | 0.160 |
Why?
|
Pteridines | 1 | 2018 | 47 | 0.160 |
Why?
|
Complement Activation | 1 | 2020 | 446 | 0.160 |
Why?
|
Cell Line | 12 | 2023 | 15620 | 0.160 |
Why?
|
Neurons | 1 | 2018 | 9426 | 0.160 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2002 | 662 | 0.160 |
Why?
|
Squalene | 1 | 2018 | 35 | 0.160 |
Why?
|
Polysorbates | 1 | 2018 | 43 | 0.160 |
Why?
|
Genes, gag | 3 | 2010 | 56 | 0.160 |
Why?
|
Glycosylation | 5 | 2020 | 1096 | 0.150 |
Why?
|
Treatment Outcome | 15 | 2021 | 65017 | 0.150 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2021 | 1894 | 0.150 |
Why?
|
Patient Dropouts | 1 | 2020 | 412 | 0.150 |
Why?
|
Complement System Proteins | 2 | 2018 | 782 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2020 | 492 | 0.150 |
Why?
|
Respiratory System | 1 | 2021 | 557 | 0.150 |
Why?
|
Homosexuality, Male | 2 | 2023 | 1273 | 0.150 |
Why?
|
Mutation | 7 | 2020 | 29932 | 0.150 |
Why?
|
Chemokine CCL3 | 2 | 2010 | 84 | 0.150 |
Why?
|
Withholding Treatment | 2 | 2020 | 613 | 0.150 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 463 | 0.150 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2019 | 326 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 814 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1714 | 0.150 |
Why?
|
Flavivirus Infections | 1 | 2017 | 15 | 0.150 |
Why?
|
Trachea | 1 | 2023 | 1082 | 0.150 |
Why?
|
Up-Regulation | 2 | 2022 | 4122 | 0.150 |
Why?
|
Binding Sites | 6 | 2021 | 6048 | 0.150 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2017 | 13 | 0.150 |
Why?
|
Immunophenotyping | 2 | 2014 | 1871 | 0.150 |
Why?
|
Drug Therapy, Combination | 3 | 2019 | 6498 | 0.150 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2022 | 772 | 0.150 |
Why?
|
Genes, MHC Class I | 2 | 1995 | 240 | 0.150 |
Why?
|
Interleukin-10 | 1 | 2023 | 1175 | 0.140 |
Why?
|
RNA Virus Infections | 1 | 2017 | 18 | 0.140 |
Why?
|
Animals, Newborn | 3 | 2020 | 2672 | 0.140 |
Why?
|
Liposomes | 1 | 2021 | 777 | 0.140 |
Why?
|
Polysaccharides | 3 | 2023 | 1016 | 0.140 |
Why?
|
Syndrome | 1 | 2023 | 3280 | 0.140 |
Why?
|
Genes, Bacterial | 1 | 2020 | 1071 | 0.140 |
Why?
|
Platelet Activation | 1 | 2020 | 660 | 0.140 |
Why?
|
Ligands | 4 | 2011 | 3276 | 0.140 |
Why?
|
Aspartate Aminotransferases | 1 | 2018 | 416 | 0.140 |
Why?
|
Mannose | 1 | 2017 | 121 | 0.140 |
Why?
|
Immunologic Techniques | 1 | 2017 | 213 | 0.140 |
Why?
|
Autopsy | 1 | 2020 | 1007 | 0.140 |
Why?
|
RNA Phages | 1 | 2016 | 3 | 0.140 |
Why?
|
Immunity | 2 | 2018 | 998 | 0.130 |
Why?
|
Computational Biology | 5 | 2021 | 3505 | 0.130 |
Why?
|
Sequence Analysis, DNA | 5 | 2017 | 4713 | 0.130 |
Why?
|
Endometriosis | 1 | 2024 | 874 | 0.130 |
Why?
|
Cell Proliferation | 5 | 2017 | 10446 | 0.130 |
Why?
|
Biocompatible Materials | 2 | 2021 | 1689 | 0.130 |
Why?
|
Systems Analysis | 1 | 2017 | 169 | 0.130 |
Why?
|
Receptors, NK Cell Lectin-Like | 1 | 2015 | 30 | 0.130 |
Why?
|
Anti-HIV Agents | 4 | 2021 | 4491 | 0.130 |
Why?
|
Feces | 3 | 2017 | 1455 | 0.130 |
Why?
|
Dizziness | 1 | 2018 | 257 | 0.130 |
Why?
|
AIDS Serodiagnosis | 1 | 2017 | 216 | 0.130 |
Why?
|
Antibodies, Bispecific | 1 | 2018 | 191 | 0.130 |
Why?
|
Genes, Viral | 2 | 2009 | 650 | 0.120 |
Why?
|
Puerto Rico | 1 | 2016 | 373 | 0.120 |
Why?
|
Aging | 2 | 2021 | 8651 | 0.120 |
Why?
|
Needles | 2 | 2019 | 451 | 0.120 |
Why?
|
Electrophoresis, Capillary | 1 | 2014 | 63 | 0.120 |
Why?
|
Africa, Southern | 2 | 2024 | 59 | 0.120 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15840 | 0.120 |
Why?
|
Injections, Subcutaneous | 3 | 2022 | 680 | 0.120 |
Why?
|
Interleukin-17 | 1 | 2020 | 910 | 0.120 |
Why?
|
Listeria | 1 | 2014 | 25 | 0.120 |
Why?
|
Structure-Activity Relationship | 1 | 2020 | 3084 | 0.120 |
Why?
|
Liver | 5 | 2015 | 7509 | 0.120 |
Why?
|
Back Pain | 1 | 2018 | 543 | 0.120 |
Why?
|
Antigen-Antibody Complex | 2 | 2015 | 513 | 0.120 |
Why?
|
Th17 Cells | 1 | 2020 | 787 | 0.120 |
Why?
|
Cerebrospinal Fluid | 1 | 2017 | 544 | 0.110 |
Why?
|
Receptors, Virus | 2 | 2020 | 639 | 0.110 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2020 | 831 | 0.110 |
Why?
|
Retroviridae Proteins | 1 | 2013 | 94 | 0.110 |
Why?
|
Interleukin-4 | 1 | 2017 | 1130 | 0.110 |
Why?
|
Antigens, Heterophile | 1 | 2014 | 70 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2024 | 58995 | 0.110 |
Why?
|
Vasculitis | 1 | 2018 | 523 | 0.110 |
Why?
|
Cohort Studies | 6 | 2022 | 41335 | 0.110 |
Why?
|
Human Immunodeficiency Virus Proteins | 1 | 2013 | 59 | 0.110 |
Why?
|
Skin Absorption | 1 | 2013 | 94 | 0.110 |
Why?
|
Weight Loss | 2 | 2022 | 2686 | 0.110 |
Why?
|
Flow Cytometry | 7 | 2019 | 5870 | 0.110 |
Why?
|
Cells, Cultured | 6 | 2020 | 18957 | 0.110 |
Why?
|
Necrosis | 1 | 2018 | 1612 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.110 |
Why?
|
Alternative Splicing | 1 | 2018 | 1091 | 0.110 |
Why?
|
Immunoenzyme Techniques | 2 | 2006 | 1705 | 0.110 |
Why?
|
Polyomavirus | 1 | 1994 | 234 | 0.110 |
Why?
|
Nanocapsules | 1 | 2014 | 92 | 0.110 |
Why?
|
Parvoviridae | 1 | 2012 | 7 | 0.110 |
Why?
|
Maternal Exposure | 1 | 2020 | 1045 | 0.110 |
Why?
|
Picornaviridae | 1 | 2012 | 14 | 0.110 |
Why?
|
Chimera | 1 | 2014 | 453 | 0.110 |
Why?
|
Microinjections | 1 | 2013 | 321 | 0.110 |
Why?
|
Cysteine Endopeptidases | 1 | 1995 | 548 | 0.110 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 465 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 652 | 0.100 |
Why?
|
Interferons | 1 | 2016 | 705 | 0.100 |
Why?
|
Regression Analysis | 2 | 2020 | 6360 | 0.100 |
Why?
|
Aged | 13 | 2024 | 169152 | 0.100 |
Why?
|
Multiple Organ Failure | 1 | 2015 | 386 | 0.100 |
Why?
|
Transfection | 6 | 2016 | 5781 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1502 | 0.100 |
Why?
|
Microcephaly | 1 | 2016 | 425 | 0.100 |
Why?
|
Sensitivity and Specificity | 3 | 2024 | 14660 | 0.100 |
Why?
|
Administration, Intravaginal | 1 | 2012 | 151 | 0.100 |
Why?
|
South Africa | 4 | 2022 | 1821 | 0.100 |
Why?
|
Protein Stability | 1 | 2014 | 566 | 0.100 |
Why?
|
Models, Immunological | 2 | 2013 | 513 | 0.100 |
Why?
|
HIV Fusion Inhibitors | 1 | 2012 | 82 | 0.100 |
Why?
|
Cyclohexanes | 1 | 2012 | 152 | 0.100 |
Why?
|
Antigens, CD | 3 | 2014 | 4000 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2018 | 1063 | 0.100 |
Why?
|
Boston | 1 | 2024 | 9280 | 0.100 |
Why?
|
Diarrhea | 1 | 2018 | 1319 | 0.100 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 911 | 0.100 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 801 | 0.090 |
Why?
|
Models, Molecular | 6 | 2021 | 5434 | 0.090 |
Why?
|
HEK293 Cells | 4 | 2021 | 4264 | 0.090 |
Why?
|
Aerosols | 1 | 2014 | 632 | 0.090 |
Why?
|
Fatigue | 1 | 2018 | 1544 | 0.090 |
Why?
|
Species Specificity | 2 | 2012 | 2418 | 0.090 |
Why?
|
Goals | 1 | 2016 | 708 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9467 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 2 | 2020 | 1903 | 0.090 |
Why?
|
Electroporation | 2 | 2013 | 255 | 0.090 |
Why?
|
Virus Internalization | 2 | 2020 | 494 | 0.090 |
Why?
|
Membrane Glycoproteins | 4 | 2014 | 3707 | 0.090 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 830 | 0.090 |
Why?
|
Toll-Like Receptor 9 | 1 | 2012 | 234 | 0.090 |
Why?
|
Spleen | 2 | 2015 | 2298 | 0.090 |
Why?
|
HIV Seronegativity | 1 | 2011 | 208 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2018 | 884 | 0.090 |
Why?
|
Apoptosis | 2 | 2018 | 9501 | 0.090 |
Why?
|
Carrier State | 1 | 2014 | 525 | 0.090 |
Why?
|
Melanoma | 2 | 2021 | 5697 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2005 | 4166 | 0.090 |
Why?
|
Tissue Donors | 1 | 2020 | 2313 | 0.090 |
Why?
|
Poly I-C | 1 | 2010 | 112 | 0.090 |
Why?
|
Comorbidity | 2 | 2022 | 10551 | 0.090 |
Why?
|
Gene Deletion | 2 | 2016 | 2668 | 0.090 |
Why?
|
Hemorrhage | 1 | 2002 | 3600 | 0.090 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 979 | 0.090 |
Why?
|
HIV Protease | 1 | 2010 | 97 | 0.090 |
Why?
|
DNA, Recombinant | 2 | 2010 | 455 | 0.090 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 961 | 0.090 |
Why?
|
Immunotherapy | 2 | 2004 | 4642 | 0.080 |
Why?
|
HLA-A Antigens | 3 | 2011 | 225 | 0.080 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2009 | 85 | 0.080 |
Why?
|
Recombinant Proteins | 4 | 2014 | 6538 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4573 | 0.080 |
Why?
|
Poxviridae | 2 | 2010 | 37 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2514 | 0.080 |
Why?
|
Calcinosis | 1 | 2018 | 1476 | 0.080 |
Why?
|
HLA Antigens | 2 | 2010 | 1368 | 0.080 |
Why?
|
Blood | 1 | 2011 | 586 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2825 | 0.080 |
Why?
|
Flavivirus | 2 | 2020 | 22 | 0.080 |
Why?
|
Gestational Age | 1 | 2018 | 3565 | 0.080 |
Why?
|
Mammary Glands, Animal | 1 | 2010 | 271 | 0.080 |
Why?
|
Research Design | 2 | 2023 | 6180 | 0.080 |
Why?
|
Major Histocompatibility Complex | 2 | 2005 | 928 | 0.080 |
Why?
|
Ectromelia virus | 1 | 2008 | 5 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3539 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2125 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3839 | 0.080 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2020 | 81 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2022 | 6544 | 0.080 |
Why?
|
Lipids | 2 | 2022 | 3336 | 0.080 |
Why?
|
Prospective Studies | 4 | 2021 | 54303 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2852 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1959 | 0.080 |
Why?
|
Age Factors | 2 | 2022 | 18416 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2648 | 0.080 |
Why?
|
Chemokine CCL4 | 2 | 2004 | 126 | 0.080 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 587 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2058 | 0.080 |
Why?
|
Polymerase Chain Reaction | 7 | 2017 | 6068 | 0.070 |
Why?
|
Escherichia coli | 2 | 2019 | 4219 | 0.070 |
Why?
|
Macrophage Inflammatory Proteins | 2 | 2004 | 121 | 0.070 |
Why?
|
Cattle | 2 | 2017 | 3847 | 0.070 |
Why?
|
Recurrence | 1 | 2020 | 8482 | 0.070 |
Why?
|
Research | 1 | 2016 | 1974 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2698 | 0.070 |
Why?
|
Birds | 1 | 2008 | 168 | 0.070 |
Why?
|
Virus Diseases | 2 | 2006 | 720 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2013 | 1347 | 0.070 |
Why?
|
Point Mutation | 3 | 2004 | 1594 | 0.070 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14495 | 0.070 |
Why?
|
Heterocyclic Compounds, 3-Ring | 2 | 2021 | 279 | 0.070 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 276 | 0.070 |
Why?
|
Biological Evolution | 2 | 2023 | 1074 | 0.070 |
Why?
|
Hospitalization | 3 | 2022 | 10790 | 0.070 |
Why?
|
Child | 5 | 2024 | 79806 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2057 | 0.070 |
Why?
|
Case-Control Studies | 4 | 2024 | 22053 | 0.070 |
Why?
|
Monocytes | 1 | 2016 | 2575 | 0.070 |
Why?
|
Triazoles | 1 | 2012 | 904 | 0.070 |
Why?
|
Microspheres | 2 | 2021 | 787 | 0.070 |
Why?
|
Influenza, Human | 1 | 2017 | 1528 | 0.070 |
Why?
|
Colon | 1 | 2014 | 1788 | 0.070 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2010 | 581 | 0.070 |
Why?
|
Glycoproteins | 1 | 2014 | 2208 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10827 | 0.070 |
Why?
|
Incidence | 4 | 2022 | 21392 | 0.060 |
Why?
|
Chemoprevention | 1 | 2008 | 326 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 1693 | 0.060 |
Why?
|
Bone Marrow | 1 | 2016 | 2912 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4407 | 0.060 |
Why?
|
Polymers | 1 | 2013 | 1621 | 0.060 |
Why?
|
Drug Combinations | 2 | 2022 | 2025 | 0.060 |
Why?
|
Signal Transduction | 4 | 2021 | 23376 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2008 | 428 | 0.060 |
Why?
|
Phenotype | 5 | 2017 | 16546 | 0.060 |
Why?
|
Defective Viruses | 2 | 2019 | 89 | 0.060 |
Why?
|
Bacteria | 1 | 2016 | 2199 | 0.060 |
Why?
|
HLA-B7 Antigen | 1 | 2004 | 50 | 0.060 |
Why?
|
Injections, Intradermal | 2 | 2016 | 116 | 0.060 |
Why?
|
Immunity, Active | 1 | 2004 | 58 | 0.060 |
Why?
|
Trichosporon | 1 | 2003 | 9 | 0.060 |
Why?
|
Palatine Tonsil | 1 | 2024 | 193 | 0.060 |
Why?
|
Molecular Probes | 1 | 2005 | 313 | 0.060 |
Why?
|
3T3 Cells | 1 | 2005 | 1085 | 0.060 |
Why?
|
Intestines | 1 | 2012 | 1907 | 0.050 |
Why?
|
DNA Replication | 1 | 2010 | 1412 | 0.050 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2020 | 453 | 0.050 |
Why?
|
Acute Disease | 3 | 2021 | 7269 | 0.050 |
Why?
|
Viral Structural Proteins | 1 | 2003 | 95 | 0.050 |
Why?
|
Herpesvirus 4, Human | 2 | 2001 | 1075 | 0.050 |
Why?
|
Measles virus | 1 | 2003 | 67 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39261 | 0.050 |
Why?
|
Histone Deacetylase 2 | 1 | 2022 | 72 | 0.050 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2209 | 0.050 |
Why?
|
COS Cells | 1 | 2004 | 1129 | 0.050 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 62 | 0.050 |
Why?
|
Computer Simulation | 2 | 2020 | 6218 | 0.050 |
Why?
|
Immune Sera | 1 | 2022 | 613 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25942 | 0.050 |
Why?
|
Chemotaxis | 1 | 2004 | 598 | 0.050 |
Why?
|
Binding, Competitive | 2 | 2020 | 1142 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2020 | 2440 | 0.050 |
Why?
|
Sulfonic Acids | 1 | 2021 | 102 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2009 | 2753 | 0.050 |
Why?
|
Saccharomycetales | 1 | 2021 | 74 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2022 | 131 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 2001 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2005 | 0.050 |
Why?
|
Measles | 1 | 2003 | 185 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 172 | 0.050 |
Why?
|
Phagocytosis | 2 | 2017 | 1535 | 0.050 |
Why?
|
Limit of Detection | 1 | 2021 | 280 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11903 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2017 | 3616 | 0.040 |
Why?
|
Transcription Factors | 2 | 2022 | 12103 | 0.040 |
Why?
|
Mycoses | 1 | 2003 | 387 | 0.040 |
Why?
|
Polyomavirus Infections | 1 | 2002 | 194 | 0.040 |
Why?
|
Viral Matrix Proteins | 2 | 2018 | 197 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2020 | 363 | 0.040 |
Why?
|
Disease Progression | 3 | 2022 | 13502 | 0.040 |
Why?
|
Proteins | 2 | 2010 | 6029 | 0.040 |
Why?
|
Albumins | 1 | 2022 | 575 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 438 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 2696 | 0.040 |
Why?
|
Thailand | 1 | 2020 | 289 | 0.040 |
Why?
|
Surface Plasmon Resonance | 2 | 2012 | 265 | 0.040 |
Why?
|
Protein Conformation | 3 | 2021 | 3969 | 0.040 |
Why?
|
Administration, Sublingual | 1 | 2019 | 58 | 0.040 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
United States | 4 | 2022 | 72461 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13262 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2008 | 4357 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12922 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2017 | 1982 | 0.040 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2005 | 615 | 0.040 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2001 | 303 | 0.040 |
Why?
|
Stearic Acids | 1 | 2019 | 56 | 0.040 |
Why?
|
Biomedical Research | 1 | 2014 | 3426 | 0.040 |
Why?
|
Antibody-Dependent Enhancement | 1 | 2018 | 15 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2000 | 562 | 0.040 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 1996 | 224 | 0.040 |
Why?
|
Bioreactors | 1 | 2019 | 244 | 0.040 |
Why?
|
Guillain-Barre Syndrome | 1 | 2019 | 125 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 606 | 0.040 |
Why?
|
Amides | 1 | 2021 | 448 | 0.040 |
Why?
|
Body Temperature | 1 | 2021 | 777 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2017 | 2536 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2018 | 224 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2018 | 364 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9585 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2006 | 1403 | 0.040 |
Why?
|
Macaca nemestrina | 1 | 2017 | 21 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 435 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2002 | 1737 | 0.040 |
Why?
|
Body Weight | 1 | 2008 | 4611 | 0.040 |
Why?
|
Drug Substitution | 1 | 2020 | 296 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 1998 | 915 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 457 | 0.040 |
Why?
|
Infant | 2 | 2011 | 36060 | 0.030 |
Why?
|
Intestine, Small | 1 | 2023 | 1207 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2005 | 11071 | 0.030 |
Why?
|
Binding Sites, Antibody | 1 | 2017 | 337 | 0.030 |
Why?
|
Solubility | 1 | 1998 | 1088 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2016 | 76 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2021 | 1069 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2017 | 245 | 0.030 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2001 | 975 | 0.030 |
Why?
|
Chromatography, Gel | 2 | 2012 | 645 | 0.030 |
Why?
|
Lectins | 1 | 2018 | 484 | 0.030 |
Why?
|
Injections | 1 | 2019 | 830 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13314 | 0.030 |
Why?
|
Chickens | 1 | 2017 | 860 | 0.030 |
Why?
|
Peptide Library | 1 | 1997 | 347 | 0.030 |
Why?
|
Pyridones | 1 | 2021 | 792 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1021 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 975 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2002 | 1375 | 0.030 |
Why?
|
HIV Reverse Transcriptase | 1 | 1995 | 212 | 0.030 |
Why?
|
Geography | 1 | 2017 | 661 | 0.030 |
Why?
|
Cryoelectron Microscopy | 2 | 2009 | 642 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2016 | 428 | 0.030 |
Why?
|
Reference Standards | 1 | 2018 | 1004 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1091 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2488 | 0.030 |
Why?
|
Orthopoxvirus | 1 | 2013 | 11 | 0.030 |
Why?
|
Simian virus 40 | 1 | 1994 | 291 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1055 | 0.030 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2013 | 45 | 0.030 |
Why?
|
Precipitin Tests | 1 | 1994 | 814 | 0.030 |
Why?
|
Cross-Priming | 1 | 2013 | 75 | 0.030 |
Why?
|
Interferon Type I | 1 | 2017 | 559 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 4107 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 428 | 0.030 |
Why?
|
Metagenomics | 1 | 2017 | 457 | 0.030 |
Why?
|
Virus Cultivation | 1 | 2013 | 88 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1995 | 1433 | 0.030 |
Why?
|
Promoter Regions, Genetic | 2 | 2019 | 5785 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1446 | 0.030 |
Why?
|
Dogs | 1 | 2017 | 3841 | 0.030 |
Why?
|
Metagenome | 1 | 2016 | 450 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2021 | 2299 | 0.030 |
Why?
|
Ultracentrifugation | 1 | 2012 | 183 | 0.030 |
Why?
|
Molecular Weight | 1 | 2014 | 2186 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2024 | 3562 | 0.020 |
Why?
|
Transaminases | 1 | 2012 | 196 | 0.020 |
Why?
|
Rabbits | 1 | 2018 | 4773 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20080 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2013 | 713 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2012 | 389 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 848 | 0.020 |
Why?
|
Brain | 1 | 2018 | 26951 | 0.020 |
Why?
|
Allergy and Immunology | 1 | 2012 | 175 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2017 | 9530 | 0.020 |
Why?
|
Lymphocyte Count | 2 | 2004 | 780 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2014 | 1156 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36290 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2525 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1433 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5201 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2013 | 1342 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2004 | 7850 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2012 | 929 | 0.020 |
Why?
|
Fowlpox virus | 1 | 2009 | 21 | 0.020 |
Why?
|
Cowpox virus | 1 | 2008 | 1 | 0.020 |
Why?
|
Encephalitis Virus, Venezuelan Equine | 1 | 2008 | 7 | 0.020 |
Why?
|
Comet Assay | 1 | 2008 | 74 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3607 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6771 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9411 | 0.020 |
Why?
|
DNA | 2 | 2019 | 7233 | 0.020 |
Why?
|
Mycobacterium smegmatis | 1 | 2008 | 124 | 0.020 |
Why?
|
Bioterrorism | 1 | 2008 | 144 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1190 | 0.020 |
Why?
|
Adenovirus E4 Proteins | 1 | 2006 | 7 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4625 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4925 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12531 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2009 | 1167 | 0.020 |
Why?
|
Adenovirus E1 Proteins | 1 | 2005 | 6 | 0.020 |
Why?
|
Retroviruses, Simian | 1 | 2005 | 12 | 0.020 |
Why?
|
Adenovirus E3 Proteins | 1 | 2005 | 7 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1006 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2006 | 555 | 0.020 |
Why?
|
Equipment Design | 1 | 2013 | 3520 | 0.020 |
Why?
|
Diamines | 1 | 2005 | 59 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 617 | 0.020 |
Why?
|
Antigens, Nuclear | 1 | 2005 | 184 | 0.010 |
Why?
|
Organic Chemicals | 1 | 2005 | 211 | 0.010 |
Why?
|
Risk Factors | 2 | 2022 | 74359 | 0.010 |
Why?
|
Benzothiazoles | 1 | 2005 | 246 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1995 | 4291 | 0.010 |
Why?
|
Vimentin | 1 | 2005 | 255 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.010 |
Why?
|
Body Mass Index | 1 | 2021 | 12914 | 0.010 |
Why?
|
Restriction Mapping | 1 | 2004 | 852 | 0.010 |
Why?
|
Child, Preschool | 1 | 2006 | 42063 | 0.010 |
Why?
|
India | 1 | 2010 | 2336 | 0.010 |
Why?
|
Culture Media | 1 | 2005 | 900 | 0.010 |
Why?
|
Herpesvirus 8, Human | 1 | 2005 | 255 | 0.010 |
Why?
|
History, 20th Century | 1 | 2011 | 2773 | 0.010 |
Why?
|
Haplorhini | 1 | 2003 | 529 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12960 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 2003 | 285 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5889 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10344 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3800 | 0.010 |
Why?
|
Organ Specificity | 1 | 2006 | 1955 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1526 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2010 | 2013 | 0.010 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2004 | 663 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11481 | 0.010 |
Why?
|
Hepatocytes | 1 | 2008 | 1229 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2010 | 1889 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7475 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26181 | 0.010 |
Why?
|
Quinolines | 1 | 2005 | 759 | 0.010 |
Why?
|
Warfarin | 1 | 2008 | 1518 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4466 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9276 | 0.010 |
Why?
|
California | 1 | 2003 | 1416 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1997 | 6131 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1998 | 321 | 0.010 |
Why?
|
Leukemia, Basophilic, Acute | 1 | 1997 | 15 | 0.010 |
Why?
|
Cell Degranulation | 1 | 1997 | 276 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15757 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 80372 | 0.010 |
Why?
|
Models, Statistical | 1 | 2009 | 5075 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 4938 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4048 | 0.010 |
Why?
|
Coloring Agents | 1 | 1996 | 562 | 0.010 |
Why?
|
DNA Probes | 1 | 1995 | 551 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2003 | 1758 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2006 | 3826 | 0.010 |
Why?
|
Burkitt Lymphoma | 1 | 1995 | 333 | 0.010 |
Why?
|
Kenya | 1 | 1995 | 749 | 0.010 |
Why?
|
Exons | 1 | 1995 | 2388 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12965 | 0.000 |
Why?
|
Gene Frequency | 1 | 1995 | 3615 | 0.000 |
Why?
|
Rats | 1 | 1997 | 23711 | 0.000 |
Why?
|